Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 Open-label Study of TAK-850 Influenza Vaccine in Healthy Adults
jRCT2080222419Phase 2
- Sponsor
- Takeda
- Start
- Mar 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of TAK-850 in influenza, sponsored by Takeda.
02
Drugs
TAK-850
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080222419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222419.